Cargando…

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients

BACKGROUND: Pain strongly coexists with depression. Ketamine has great analgesic and antidepressant effects, acting as a promising role in treating depression with pain. Few studies have evaluated impact of pain symptoms on antidepressant effect of ketamine infusions. Thus, present study investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Xiaofeng, Zhou, Yanling, Wang, Chengyu, Li, Weicheng, Zhang, Fan, Liu, Haiyan, Fu, Ling, Wu, Kai, McIntyre, Roger S., Ning, Yuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967176/ https://www.ncbi.nlm.nih.gov/pubmed/35370832 http://dx.doi.org/10.3389/fpsyt.2022.793677

Ejemplares similares

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
por: Zhou, Yanling, et al.
Publicado: (2022)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

The functional connectivity of the middle frontal cortex predicts ketamine’s outcome in major depressive disorder
por: Zhang, Fan, et al.
Publicado: (2022)

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
por: Zhou, Yanling, et al.
Publicado: (2021)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
por: Ye, Yanxiang, et al.
Publicado: (2022)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

The core inflammatory factors in patients with major depressive disorder: a network analysis
por: Zeng, Yexian, et al.
Publicado: (2023)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
por: Andrashko, Veronika, et al.
Publicado: (2020)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress Model
por: Wen, Gehua, et al.
Publicado: (2019)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
por: Lan, Xiaofeng, et al.
Publicado: (2023)

The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression
por: McDonnell, Conor W., et al.
Publicado: (2021)

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Sirtuin Type 1 Mediates the Antidepressant Effect of S-Ketamine in a Chronic Unpredictable Stress Model
por: Hou, Lanwei, et al.
Publicado: (2022)

Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness
por: Roughan, William H., et al.
Publicado: (2021)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity
por: Kang, Melody J. Y., et al.
Publicado: (2022)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
por: Liu, Haiyan, et al.
Publicado: (2022)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Aberrant Dynamic Functional Connectivity of Posterior Cingulate Cortex Subregions in Major Depressive Disorder With Suicidal Ideation
por: Li, Weicheng, et al.
Publicado: (2022)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

Controversies of the Effect of Ketamine on Cognition
por: Zhang, Melvyn W. B., et al.
Publicado: (2016)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

Is There a Role of Autophagy in Depression and Antidepressant Action?
por: Gassen, Nils C., et al.
Publicado: (2019)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression
por: Zheng, Wei, et al.
Publicado: (2021)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Network Analyses of Maternal Pre- and Post-Partum Symptoms of Depression and Anxiety
por: Phua, Desiree Y., et al.
Publicado: (2020)

The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis
por: Ma, Haijing, et al.
Publicado: (2022)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Prescribing behavior of antidepressants for depressive disorders: A systematic review
por: Lam, Mary K., et al.
Publicado: (2022)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6u4iprtfkn3duiejomdcutdj38